Health Condition 1: M968- Other intraoperative and postprocedural complications and disorders of musculoskeletal system, not elsewhere classified
Conditions
Interventions
Intervention1: Dexmedetomidine: Study participants will be
randomized into two groups.
Intervention group will receive 40 ml of 0.375% perineural ropivacaine (femoro-sciatic nerve blocks) with with 0.
Sponsors
GOKULNATH THANGARAJ
Eligibility
Inclusion criteria
Inclusion criteria: 1. Patients of age group 18 to 60 years. 2. Patients of American Society of Anaesthesiologists (ASA) physical grade I or II.
Exclusion criteria
Exclusion criteria: 1. Hypersensitivity to the amide group of local anaesthetic agents and dexmedetomidine. 2. Patients having hypertension/diabetes mellitus / neuropathy / peripheral nerve injury 3. Pregnancy and lactation 4. Patient on anticoagulants or bleeding disorder 5. Patients having problems in communication 6. Infection at the site of drug injection.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| to access the Motor and Sensory Block characteristicsTimepoint: Outcome will be assessed from the point of administration of femoro-sciatic nerve block till 24hrs after the surgery. Data will be then assessed at the end of two years. | — |
Secondary
| Measure | Time frame |
|---|---|
| NILTimepoint: NIL | — |
Countries
India
Contacts
Public ContactDr N RATAN SINGH
Regional Institute of Medical Sciences, Imphal, Manipur
Outcome results
None listed